Skip to main content
Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
71.05
+0.49 (0.69%)
Nov 20, 2024, 4:00 PM EST - Market closed

Incyte Revenue

Incyte had revenue of $1.14B in the quarter ending September 30, 2024, with 23.81% growth. This brings the company's revenue in the last twelve months to $4.08B, up 12.94% year-over-year. In the year 2023, Incyte had annual revenue of $3.70B with 8.87% growth.

Revenue (ttm)
$4.08B
Revenue Growth
+12.94%
P/S Ratio
3.75
Revenue / Employee
$1,614,842
Employees
2,524
Market Cap
13.69B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.70B301.01M8.87%
Dec 31, 20223.39B408.37M13.67%
Dec 31, 20212.99B319.57M11.98%
Dec 31, 20202.67B507.94M23.53%
Dec 31, 20192.16B276.88M14.71%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Tenet Healthcare 20.97B
Universal Health Services 15.42B
Viatris 15.05B
Avantor 6.82B
Moderna 5.08B
Genmab 2.97B
Revvity 2.72B
Royalty Pharma 2.27B
Revenue Rankings

INCY News

More News